RecruitingNot ApplicableNCT06283862
MIVetsCan: Can-Coach Trial (Phase 2)
MIVetsCan: Cannabis Coaching for Veteran Pain Management Trial (Phase 2)
Sponsor
University of Michigan
Enrollment
468 participants
Start Date
Apr 4, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of the MIVetsCan Can-Coach Trial is to test four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- United States Veteran
- Experiencing chronic pain (pain lasting 3 or more months)
- Moderate to severe chronic pain
- Are planning or currently using cannabidiol (CBD) or cannabis products for pain management
- Able to read and speak English sufficiently to allow for informed consent and active participation in the educational intervention sessions
- Willingness to attend all study visits (conducted virtually)
- Willingness to fill out periodic assessments via smartphone to assess symptom status and cannabis use (protocol has more details)
Exclusion Criteria8
- Inability to provide informed consent (e.g., cognitive impairment, unable to sufficiently communicate in English)
- Participant states participant is pregnant
- Planning to move out of a state with legal recreational marijuana use during course of study;
- Current diagnosis or past history of a psychotic disorder (schizophrenia spectrum, except substance/medication -induced or due to another condition)
- Current diagnosis or past history of bipolar disorder
- Unable to attend study visits
- Risk for imminent harm - Suicidal ideation or wish to die as assessed with the Positive and Negative Suicide Ideation (PANSI) questionnaire and further risk assessment by study team members
- Any impairment, activity, behavior, or situation that in the judgment of the study team would prevent satisfactory completion of the study protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALEducational Session
The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06283862
Related Trials
Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
NCT049396231 location
Mindfulness-based Rehabilitation in a University Museum Setting to Reduce Pain and Improve Quality of Life in Women With Fibromyalgia: a Randomized Controlled Trial
NCT070483662 locations
Reducing Opioid Use for Chronic Pain Patients Following Surgery
NCT036753861 location
Mindfulness-Based Ecological Momentary Intervention for Opioid Use Disorder and Chronic Pain
NCT069471222 locations
Interoceptive Awareness and Function in Adolescents With Chronic Pain
NCT073251101 location